What are the recommended sick‑day management guidelines for a patient with diabetes, including medication adjustments, glucose and ketone monitoring, and hydration?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 14, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Sick Day Rules for Diabetes Patients

When a diabetes patient develops acute illness with vomiting, diarrhea, or significantly reduced fluid intake, they should temporarily stop SGLT2 inhibitors, metformin, ACE inhibitors/ARBs, diuretics, and NSAIDs for up to 72 hours while increasing fluid intake and monitoring blood glucose every 4-6 hours. 1

When to Initiate Sick Day Rules

Trigger sick day management when the patient experiences any of the following NEW or WORSENED symptoms indicating volume depletion 1:

  • Vomiting or diarrhea causing significant fluid losses (100% consensus)
  • Nausea or anorexia reducing fluid intake substantially (88% consensus)
  • Lightheadedness, dizziness, or orthostatic symptoms (88% consensus)
  • Weight loss of 3 kg in 2 days (83% consensus)
  • Decreased urine output (75% consensus)

Medication Adjustments

Medications to STOP Temporarily (for up to 3 days or until symptoms resolve) 1:

High priority to stop:

  • SGLT2 inhibitors (empagliflozin, dapagliflozin, canagliflozin) - 96% consensus
  • Metformin - 86% consensus
  • ACE inhibitors/ARBs (perindopril, candesartan, lisinopril, losartan) - 90% consensus
  • All diuretics:
    • Loop diuretics (furosemide) - 95% consensus
    • Thiazide/thiazide-like (HCTZ, indapamide) - 90% consensus
    • Potassium-sparing (spironolactone, amiloride) - 95% consensus
  • NSAIDs - 95% consensus
  • ARNI (sacubitril/valsartan) - 88% consensus

Critical nuance: The 2023 consensus guidelines show strong agreement (86-96%) for stopping these medications because they increase risk of acute kidney injury and metabolic complications during volume depletion 1, 2.

Medications Requiring Glucose-Based Adjustment (DO NOT automatically stop) 1:

Insulin:

  • If glucose is LOW: Hold insulin until glucose recovers (96% consensus)
  • If glucose is ELEVATED: Increase basal and bolus insulin by 10-20% empirically; if unsuccessful after 24 hours, contact healthcare provider (87% consensus)
  • Never completely stop insulin in type 1 diabetes - this is a critical pitfall that can precipitate DKA

Sulfonylureas/Meglitinides:

  • If glucose is LOW: Hold until glucose recovers (96% consensus)
  • If already taken: Eat foods to prevent hypoglycemia for 12-24 hours until medication effect wears off (78% consensus)

GLP-1 receptor agonists: Did NOT reach consensus for routine stopping (only 57% agreement) - continue unless specific contraindications 1

Monitoring Requirements

Blood Glucose Monitoring 1:

  • Patients on insulin: Check every 4-6 hours while awake for duration of symptoms (100% consensus)
  • This is MORE frequent than usual monitoring

Ketone Monitoring 1:

  • Check ketones if patient takes:
    • SGLT2 inhibitors (95% consensus)
    • Insulin (95% consensus)
    • Following ketogenic diet (95% consensus)
  • Use blood ketone meters when available (more accurate than urine) 3

Hydration 1:

  • Increase fluid intake with limited caffeine (92% consensus)
  • Consider electrolyte replacement solutions (92% consensus)
  • This is essential to reverse volume depletion and prevent acute kidney injury 2

When to Contact Healthcare Provider

Seek assistance from healthcare provider when: 1

  • Patient feels unable to cope (100% consensus)
  • Symptoms persist beyond 72 hours (100% consensus)
  • Cannot keep down foods or fluids (100% consensus)
  • Recurrent low blood glucose readings (96% consensus)
  • Blood glucose remains significantly elevated despite self-adjustment after 24 hours (96% consensus)
  • Moderate or high ketones detected (91% consensus)
  • Vomiting >4 times in 12 hours (96% consensus)
  • Blood pressure drops (SBP <80 mmHg or drop of 20 mmHg systolic/10 mmHg diastolic) - 92% consensus
  • Heart rate increases by 30 bpm (79% consensus)
  • Fever >38°C (101°F) on 2 measurements (75% consensus)

When to Call 911/Seek Emergency Care

Immediately seek emergency care for: 1

  • Difficulty or rapid breathing (100% consensus)
  • Reduced consciousness or new confusion (96% consensus)
  • Fainting or falls (71% consensus)

These symptoms suggest impending DKA, severe dehydration, or other life-threatening complications 4, 5.

Resuming Medications

Timeline for restarting medications after symptoms resolve: 1

  • Medications causing hypoglycemia (insulin, sulfonylureas): Resume at usual doses as soon as symptoms improve AND normal eating/drinking resumes (100% consensus)
  • Volume-depleting medications (diuretics, ACE inhibitors/ARBs): Resume at usual doses within 24-48 hours of eating and drinking normally (95% consensus)
  • All other temporarily stopped medications: Resume at usual doses within 24-48 hours of eating and drinking normally (95% consensus)
  • If symptoms last >72 hours: Contact healthcare provider before resuming any medications (100% consensus)

Critical Pitfalls to Avoid

  1. Never completely stop insulin in type 1 diabetes - adjust based on glucose levels but maintain basal coverage to prevent DKA 4, 5
  2. Do not wait too long to check ketones - particularly important for SGLT2 inhibitor users who can develop euglycemic DKA 6
  3. Self-management is only appropriate for maximum 72 hours - beyond this, medical supervision is required 1
  4. Do not assume GLP-1 agonists need to be stopped - evidence did not support routine discontinuation 1
  5. Patients on sulfonylureas who already took their dose need carbohydrate intake to prevent delayed hypoglycemia over 12-24 hours 1

This guidance represents the 2023 international consensus from a modified Delphi process specifically designed to prevent medication-related complications during acute illness in diabetes patients 1, 2.

References

Research

Choosing wisely in practice: How sick day rules help prevent medication-related complications.

Ceska a Slovenska farmacie : casopis Ceske farmaceuticke spolecnosti a Slovenske farmaceuticke spolecnosti, 2025

Research

Sick-day management in type 1 diabetes.

Endocrinology and metabolism clinics of North America, 2000

Research

Glycemic Management in Adults With Diabetes During Illness.

Clinical diabetes : a publication of the American Diabetes Association, 2025

Research

Sick Day Management in Children and Adolescents with Type 1 Diabetes.

The Journal of the Arkansas Medical Society, 2016

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.